RB1 and neoplasm: Regarding MCPyV-positive MCCs, pRB is targeted by the Large T antigen (LT) of MCPyV as research has shown that MCPyV-LT strongly binds to RB1 only, inactivating it and thus promoting MCC tumor growth in MCPyV-positive MCCs [68].